Supply Chain Research

The U.S. government will implement new policies to provide a “safe linkage between drug supply chains” between Canada and the U.S. That’s designed to cut the costs of pharmaceuticals in the U.S. Legitimate imports of Canada were worth $4.3 billion in the 12 months to May 31 after a 30.0% surge in imports compared to the prior 12 month period, Panjiva data shows. That’s still only 5.5% of the total, which in turn increased 8.8% in the past 12 months. The fastest growing drug import classes were cardiovascular treatments which grew 42.9% year over year in the three months to May 31 and ant...